» Articles » PMID: 34588604

Vitrectomy and External Drainage of Subretinal Fluid Containing High Concentration of Vascular Endothelial Growth Factor for Advanced Coats Disease

Overview
Journal Sci Rep
Specialty Science
Date 2021 Sep 30
PMID 34588604
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated the surgical outcomes of Coats disease and the role of external drainage (XD) of subretinal fluid (SRF). The study is a multicenter retrospective interventional case series of 26 consecutive eyes of 26 patients who underwent surgeries for advanced Coats disease with retinal detachment. Main outcomes measured were: 1) comparison of complete SRF resolution with or without XD, and 2) variables that were associated with functional postoperative best-corrected visual acuity (BCVA) defined as BCVA of 0.1 or better, 3) intraocular vascular endothelial growth factor (VEGF) levels. Complete SRF resolution was achieved in all 14 eyes in which XD had been performed and in 75% of 12 eyes in which XD had not been performed (P = .03). Multivariable logistic regression analysis revealed that initial BCVA was the only variable associated with functional postoperative BCVA (odds ratio 3.24, 95% CI 0.93-11.33; P = .04). Markedly elevated VEGF levels were noted in the SRF compared with those in the vitreous humor (49,760 ± 52,990 vs. 707 ± 611 pg/mL, P = .03). XD seems to provide better anatomical success than without XD in the treatment of advanced Coats disease as XD could effectively eliminate substantial amount of VEGF in the SRF.

Citing Articles

Management of persistent exudative retinal detachment: exploring etiology and surgical outcomes.

Ozbek M, Aydin R, Artunay O BMC Ophthalmol. 2024; 24(1):493.

PMID: 39533244 PMC: 11555880. DOI: 10.1186/s12886-024-03764-4.


Surgical Drainage of Large Macular Cystoid Spaces in Coats Disease.

Yiu G, Hang A, Fong R J Vitreoretin Dis. 2024; 8(3):355-358.

PMID: 38770082 PMC: 11102732. DOI: 10.1177/24741264241240320.


Avascular Peripheral Retina in Infants.

Ozdek S, Ozdemir Zeydanli E, Baumal C, Hoyek S, Patel N, Berrocal A Turk J Ophthalmol. 2023; 53(1):44-57.

PMID: 36847634 PMC: 9973209. DOI: 10.4274/tjo.galenos.2022.76436.

References
1.
Park S, Cho H, Lee D, Kim C, Kim J . Intravitreal bevacizumab injections combined with laser photocoagulation for adult-onset Coats' disease. Graefes Arch Clin Exp Ophthalmol. 2015; 254(8):1511-1517. DOI: 10.1007/s00417-015-3233-6. View

2.
Bonfiglio V, Reibaldi M, Fallico M, Russo A, Pizzo A, Fichera S . Widening use of dexamethasone implant for the treatment of macular edema. Drug Des Devel Ther. 2017; 11:2359-2372. PMC: 5566324. DOI: 10.2147/DDDT.S138922. View

3.
Sigler E, Randolph J, Calzada J, Wilson M, Haik B . Current management of Coats disease. Surv Ophthalmol. 2013; 59(1):30-46. DOI: 10.1016/j.survophthal.2013.03.007. View

4.
Mordenti J, Thomsen K, LICKO V, Chen H, Meng Y, Ferrara N . Efficacy and concentration-response of murine anti-VEGF monoclonal antibody in tumor-bearing mice and extrapolation to humans. Toxicol Pathol. 1999; 27(1):14-21. DOI: 10.1177/019262339902700104. View

5.
Su C, Chen M, Wu W, Wu W . Concentration of vascular endothelial growth factor in the subretinal fluid of retinal detachment. J Ocul Pharmacol Ther. 2000; 16(5):463-9. DOI: 10.1089/jop.2000.16.463. View